Ocular Therapeutix

Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.

Bedford, US
Size (employees)
118 (est)+32%
Ocular Therapeutix was founded in 2006 and is headquartered in Bedford, US

Key People at Ocular Therapeutix

Amarpreet Sawhney

Amarpreet Sawhney

President and CEO
Fred Khosravi

Fred Khosravi

Co - Founder, Director & Chairman

Ocular Therapeutix Office Locations

Ocular Therapeutix has office in Bedford
Bedford, US

Ocular Therapeutix Metrics

Ocular Therapeutix Summary

Market capitalization

$274 m

Closing share price

Ocular Therapeutix's current market capitalization is $274 m.

Ocular Therapeutix Financials

Ocular Therapeutix's revenue is $1.8 m in FY, 2015 which is a 126.7% increase from the previous period.
FY, 2014FY, 2015


$772 k$1.8 m

Revenue growth, %


Net Income

($28.6 m)($39.7 m)

Ocular Therapeutix Market Value History

Ocular Therapeutix Company Life

You may also be interested in